However, the use of broad-spectrum antibiotics—which are effective against many different kinds of pathogens—can disrupt this delicate balance. By killing off the "friendly" commensal microbes, we remove microbial antagonism (the competition between good and bad microbes for space and nutrients). This can lead to opportunistic infections, where a pathogen that was previously harmless (or a microbe that was suppressed) multiplies rapidly. A classic example is Clostridium difficile, which can cause life-threatening colon inflammation if the normal flora is wiped out by long-term antibiotic use.
Mechanisms of Action: How Drugs Target Microbes
To achieve selective toxicity, drugs must target specific cellular components. The major categories of targets include cell wall synthesis, protein synthesis, cell membrane integrity, metabolic pathways, and nucleic acid synthesis.
1. Targeting Cell Wall Synthesis
Because human cells do not have a cell wall, drugs that target peptidoglycan (the primary component of bacterial cell walls) have very high selective toxicity.
- Penicillins and Derivatives: These are β-lactam drugs. They work by inhibiting "penicillin-binding proteins" (PBPs), which are the enzymes responsible for cross-linking the glycan chains in the cell wall. Derivatives like ampicillin were developed by altering the drug structure to broaden the spectrum of activity.
- Vancomycin: This is a glycopeptide that acts as a "last-resort" drug for serious infections like MRSA. It works by binding to the amino acid side chains of the peptidoglycan precursors, physically blocking the cross-linking process. Notably, vancomycin is only effective against Gram-positive bacteria because it is too large to pass through the outer membrane of Gram-negative bacteria.
2. Targeting Protein Synthesis
Many antibiotics interfere with the bacterial ribosome to prevent the production of essential proteins.
- Tetracyclines and Macrolides are key examples of drugs that disrupt the translation process in bacteria.
3. Targeting the Cytoplasmic Membrane
Some drugs, such as polyenes (e.g., nystatin), act as antifungals by attaching to ergosterol in fungal membranes to create pores. Because humans use cholesterol instead of ergosterol, these drugs exhibit selective toxicity.
4. Targeting Metabolic Pathways
- Sulfonamides: These act as antimetabolites. They are analogs of PABA, a precursor needed for bacteria to synthesize folic acid. Since humans do not synthesize folate from PABA, these drugs can target bacterial metabolism without harming the host.
5. Targeting Nucleic Acid Synthesis
- Quinolones: Drugs like ciprofloxacin interfere with DNA topoisomerase (specifically DNA gyrase), preventing the DNA from supercoiling correctly during replication.
- Rifampin: This drug prevents RNA synthesis by binding to RNA polymerase.
Measuring Drug Effectiveness
Clinicians do not just guess which drug to use; they use specific tests to determine efficacy:
- Diffusion Susceptibility Test (Kirby-Bauer): A disk containing a drug is placed on a "lawn" of bacteria. The diameter of the "zone of inhibition" (where no bacteria grow) is measured to classify the pathogen as susceptible, intermediate, or resistant.
- Minimum Inhibitory Concentration (MIC): The smallest amount of a drug required to inhibit the growth of a pathogen.
- Minimum Bactericidal Concentration (MBC): The lowest concentration required to actually kill the bacterium.
The Challenge of Drug Resistance
Drug resistance occurs when bacteria evolve mechanisms to evade the effects of antibiotics. This is often driven by selective pressure: when an antibiotic is used, it kills the susceptible bacteria, leaving only the mutants with resistance to survive and multiply.
Resistance can occur through several mechanisms:
- Enzymatic destruction: Bacteria produce enzymes like β-lactamase that physically break the β-lactam ring of penicillins, rendering them useless.
- Efflux pumps: Bacteria develop pumps that actively eject the drug from the cell.
- Target modification: A mutation might change the shape of the drug's target (like a ribosome or enzyme) so the drug can no longer bind, even though the target still functions.
Resistance can spread through vertical transfer (parent to offspring) or horizontal transfer (between neighboring microbes, often via plasmids). Human activities, such as the misuse of antibiotics, contribute significantly to this global crisis.
Clinical Reminder: If you are prescribed a 7-day course of antibiotics, you must finish the entire course even if you feel better by day 3. Stopping early can leave behind partially resistant bacteria, contributing to the rise of drug resistance.
